Literature DB >> 33904046

The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.

Aaron N Winn1,2,3, Aaron P Mitchell4, Nicole Fergestrom5,6, Joan M Neuner7,5,6, Justin G Trogdon8,9.   

Abstract

BACKGROUND: Financial relationships between physicians and the pharmaceutical and medical device industries are common, but the factors associated with physicians receiving payments are unknown.
OBJECTIVE: The objective of this study is to evaluate the influence of physicians' professional networks' characteristics on the receipt of payments among physicians.
DESIGN: Network analysis of cross-sectional data PARTICIPANTS: US physicians who shared Medicare patients with other physicians in 2015 (N=357,813). EXPOSURE (INTERVENTION): Proportion of a physician's professional network that received industry payments and other network characteristics including number of physician connections, how central the physician is within the network, and the tightness of the referral network in which a physician is located. MAIN OUTCOME MEASURES: Relative risk of receiving industry payments. We used modified Poisson regression to control for confounding by gender, time since graduation, practice size, and practice setting (teaching hospital vs. not). We included dummy variables for specialty and hospital referral region level. KEY
RESULTS: The proportion of a physician's peers in their professional network that received payments was strongly associated with receipt of pharmaceutical or device industry payments by the physician (top vs bottom quartile aRR=1.28, 95%CI=1.25-1.31). Physician's centrality within a network had a small positive effect on receiving payment (top vs bottom quartile aRR=1.02, 95%CI=1.01-1.04). Network density also had a small negative association with receipt of payment (top vs bottom quartile aRR=0.97, 95%CI=0.96-0.98).
CONCLUSIONS: Network characteristics, particularly the receipt of payments among physicians one shares patients with, are associated with whether a physician receives payments. This finding has implications for institutional regulation of industry payments to physicians and demonstrates how institutional policy may impact not only the physicians within the institution but also physicians outside of the institution.
© 2021. Society of General Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33904046      PMCID: PMC8298740          DOI: 10.1007/s11606-021-06802-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  21 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies.

Authors:  Timothy S Anderson; Chester B Good; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2018-10       Impact factor: 5.128

3.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.

Authors:  Colette DeJong; Thomas Aguilar; Chien-Wen Tseng; Grace A Lin; W John Boscardin; R Adams Dudley
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

4.  Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015.

Authors:  Kathryn R Tringale; Jona A Hattangadi-Gluth
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

5.  Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.

Authors:  Ariadna Tibau; Philippe L Bedard; Amirrtha Srikanthan; Josee-Lyne Ethier; Francisco E Vera-Badillo; Arnoud J Templeton; Alberto Ocaña; Bostjan Seruga; Agustí Barnadas; Eitan Amir
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

6.  Mapping physician networks with self-reported and administrative data.

Authors:  Michael L Barnett; Bruce E Landon; A James O'Malley; Nancy L Keating; Nicholas A Christakis
Journal:  Health Serv Res       Date:  2011-04-26       Impact factor: 3.402

7.  Variation in patient-sharing networks of physicians across the United States.

Authors:  Bruce E Landon; Nancy L Keating; Michael L Barnett; Jukka-Pekka Onnela; Sudeshna Paul; A James O'Malley; Thomas Keegan; Nicholas A Christakis
Journal:  JAMA       Date:  2012-07-18       Impact factor: 56.272

8.  Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits.

Authors:  Klaus Lieb; Armin Scheurich
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

9.  Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.

Authors:  Roy H Perlis; Clifford S Perlis
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

10.  Comparison of physician networks constructed from thresholded ties versus shared clinical episodes.

Authors:  Jukka-Pekka Onnela; A James O'Malley; Nancy L Keating; Bruce E Landon
Journal:  Appl Netw Sci       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.